Search Results - "Asher, Divya"

Measuring dose-related efficacy of eptinezumab for migraine prevention: post hoc analysis of PROMISE-1 and PROMISE-2 by Apelian, Rami, Boyle, Lee, Hirman, Joe, Asher, Divya

“…Background Eptinezumab 100 mg and 300 mg met the primary efficacy endpoint in both PROMISE clinical trials, significantly reducing frequency of monthly…”
Get full text

Early clinical experience with eptinezumab: results of a retrospective observational study of patient response in the United States by Starling, Amaal J, Kymes, Steven, Asher, Divya, Soni-Brahmbhatt, Seema, Karnik-Henry, Meghana

“…The efficacy and safety of eptinezumab for preventive migraine treatment in adults have been demonstrated in multiple, large-scale clinical trials. This…”
Get full text

Improving to Four or Fewer Monthly Headache Days Per Month Provides a Clinically Meaningful Therapeutic Target for Patients with Chronic Migraine by Kaniecki, Robert G., Friedman, Deborah I., Asher, Divya, Hirman, Joe, Cady, Roger

“…Introduction Treatment target goals for patients receiving preventive migraine treatment are complicated to assess and not achieved by most patients. A…”
Get full text

Treatment with Eptinezumab Reduces Brain Fog and Increases the Number of Good Days Per Month in Patients with Chronic Migraine in a Real-world Setting (P8-12.009) by Buse, Dawn, Soni-Brahmbhatt, Seema, Asher, Divya, Lipton, Richard B.

“…Abstract only…”
Get full text

Shift in MHDs below the threshold of preventive optimization after eptinezumab treatment in patients with migraine and history of 2–4 preventive migraine treatment failures (P5-12.010) by Starling, Amaal, Asher, Divya, Awad, Susanne, Lee, Xin Ying, Goadsby, Peter, Sperling, Bjorn

“…Abstract only…”
Get full text

Impact of Psychiatric Conditions on the Real-world Effectiveness of Eptinezumab Treatment in Patients with Chronic Migraine (P4-12.005) by Argoff, Charles, Herzog, Steven, Smith, Ryan, Soni-Brahmbhatt, Seema, Awad, Susanne, Asher, Divya, Khan, Fawad

“…Abstract only…”
Get full text

Real-world Effectiveness of Intravenous Eptinezumab in Patients with Chronic Migraine and Previous Subcutaneous Preventive Migraine Treatment (P8-12.004) by Argoff, Charles, Herzog, Steven, Smith, Ryan, Soni-Brahmbhatt, Seema, Awad, Susanne, Asher, Divya, Khan, Fawad

“…Abstract only…”
Get full text

Lack of “wearing off” effect with eptinezumab in the preventive treatment of migraine (P13-12.009) by Cady, Roger, Karnik-Henry, Meghana, Asher, Divya, Soni-Brahmbhatt, Seema, Dodick, David W.

“…Abstract only…”
Get full text

Early Clinical Experience With Eptinezumab From a Retrospective, Observational Study of Real-World Patient Response (P6-12.008) by Starling, Amaal J., Kymes, Steven, Asher, Divya, Soni-Brahmbhatt, Seema, Karnik-Henry, Meghana

“…Abstract only…”
Get full text

Patients With Chronic Migraine Improving to ≤4 Monthly Headache Days is an Effective Treatment Goal for CM (S31.002) by Kaniecki, Robert G., Friedman, Deborah I., Lipton, Richard, Asher, Divya, Hirman, Joe, Cady, Roger

“…Abstract only…”
Get full text

Patient Preferences for Attributes of Advanced Migraine Prevention Medications: Findings from a Discrete Choice Experiment (P7-12.004) by Schwedt, Todd J., Martin, Ashley, Kymes, Steven, Talon, Brian, Lee, Xin Ying, Cady, Roger, Asher, Divya, Karnik-Henry, Meghana, Mulvihill, Emily, Bates, Dawn, Beusterien, Kathleen

“…Abstract only…”
Get full text

Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment by Schwedt, Todd J., Martin, Ashley, Kymes, Steven, Talon, Brian, Lee, Xin Ying, Cady, Roger, Asher, Divya, Karnik‐Henry, Meghana, Mulvihill, Emily, Bates, Dawn, Beusterien, Kathleen

“…Objective To assess preferences among adults with migraine for differentiating attributes of injected or infused preventive treatment options and evaluate…”
Get full text